Archives
-
Bay 11-7085: NF-κB Activation Assay Guide
2026-09-09
Bay 11-7085 is a practical NF-κB activation inhibitor for connecting inflammatory signaling with cell-cycle arrest and apoptosis. This guide translates its TNFα-responsive mechanism into reproducible cell assays and shows how to interpret findings in endometriosis, neuroinflammation, and infection models without overclaiming pathway specificity.
-
Niclosamide: Practical STAT3 Assay Workflows
2026-09-09
Build more informative cancer research experiments with Niclosamide by pairing STAT3 Tyr-705 measurements with apoptosis and cell-cycle readouts. A field-trial study on molluscicide safety also offers a useful framework for exposure controls, differential sensitivity, and translational limits without implying that the compound was tested in that ecological model.
-
Cisapride in iPSC Cardiotoxicity Screening
2026-09-08
Cisapride (R 51619) offers a powerful dual-perturbation model for connecting 5-HT4 receptor signaling pathway activity with hERG channel inhibition. This article presents an assay-design framework that integrates cisapride pharmacology, iPSC-cardiomyocyte phenotyping, electrophysiology, and deep-learning analysis.
-
Humanized Mice Improve CES Prodrug PK Prediction
2026-09-08
This 2025 study shows that humanized-liver mice can reduce species-related uncertainty when evaluating the carboxylesterase prodrug HD56 and its active metabolite HD561. By combining transport, enzyme-phenotyping, microsomal, plasma, and pharmacokinetic experiments, the authors established a strong in vivo–in vitro correlation that supports more human-relevant preclinical assessment of ester prodrugs.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-09-07
Song and colleagues show that murine norovirus uses NINJ1-mediated membrane rupture as a selective route for releasing the viral protein NS1, rather than relying only on nonspecific cellular leakage. Their combination of CRISPR screening, caspase-3 perturbation, protein-interaction analysis, mutagenesis, and mouse infection experiments identifies a mechanistic link between viral protein processing, NINJ1 recruitment, and intestinal infection.
-
Mitomycin C Workflows for Cancer Research
2026-09-07
Mitomycin C combines direct DNA damage with strong experimental utility in apoptosis, sensitization, and tumor-cell proliferation assays. This guide shows how to build reproducible dose–response workflows, connect DNA replication inhibition with immune-oncology readouts, and troubleshoot solubility, timing, and interpretation problems.
-
Dextrose for Tumor Immunometabolism Workflows
2026-09-05
Use Dextrose (D-glucose) as a controlled carbon input to model nutrient competition, hypoxia adaptation, and immune-cell dysfunction in tumor microenvironment assays. This workflow combines practical concentration design, oxygen control, and troubleshooting for more reproducible glucose metabolism research.
-
Morin: Podocyte Energy Metabolism and Assay Design
2026-09-04
Morin is a natural flavonoid that links oxidative-stress biology with a newly defined AMPD2–mitochondrial energy pathway in fructose-associated podocyte injury. This guide translates the evidence into practical assay-selection, controls, and interpretation strategies.
-
EZ Cap™ EPO mRNA for Targeted Neurorepair
2026-09-04
EZ Cap™ EPO mRNA combines a Cap 1 structure, pseudouridine, and a poly(A) tail for controlled mammalian protein-expression experiments. This article translates a targeted EPO mRNA nanoparticle study into practical workflows for erythropoiesis, neuroprotection, wound-healing, and delivery research.
-
N1-Methylpseudouridine: Reliable mRNA Assays
2026-09-03
Learn how N1-Methylpseudouridine, SKU B8340, can reduce translation-related variability when researchers evaluate cell viability, proliferation, or cytotoxicity after mRNA delivery. This scenario-based guide connects formulation, controls, storage, and data interpretation to practical laboratory decisions.
-
N1-Methyl-Pseudouridine-5'-Triphosphate in Cell Assays
2026-09-03
A scenario-based guide to using N1-Methyl-Pseudouridine-5'-Triphosphate (SKU B8049) in modified-RNA workflows that support cell viability, proliferation, and cytotoxicity studies. It connects reagent specifications, in vitro transcription controls, translation evidence, assay design, and practical vendor selection.
-
Notch1–YY1–ICAM1 Axis in HCC Immunotherapy
2026-09-02
The reference study identifies the Notch1–YY1–ICAM1 pathway as a molecular determinant of immunotherapy response in hepatocellular carcinoma (HCC). Its data connect pathway disruption with stronger CD8+ T-cell cytotoxicity and granzyme-driven pyroptosis, supporting downstream targeting of YY1 as a potentially safer complement to immune checkpoint blockade.
-
ASB3 Targets MAVS to Suppress Antiviral Immunity
2026-09-02
The reference study identifies ASB3 as an E3 ubiquitin ligase that weakens antiviral innate immunity by directing K48-linked ubiquitination and proteasomal degradation of MAVS. Its gain-of-function, loss-of-function, infection, and animal experiments connect ASB3 activity to reduced interferon signaling and greater susceptibility to influenza A virus, providing a mechanistic framework for studying host regulation of RIG-I-like receptor pathways.
-
N1-Methylpseudouridine for mRNA Workflows
2026-09-01
N1-Methylpseudouridine helps researchers build higher-output mRNA assays while managing innate immune activation and translational shutdown. This guide translates the NPC1 rescue study into practical design, dosing, controls, and troubleshooting choices for reporter and disease-relevant workflows.
-
Rex-Based NADH/NAD+ Biosensor for Bacteria
2026-09-01
Liu, Landick, and Raman developed a genetically encoded, ratiometric NADH/NAD+ biosensor by coupling the redox-responsive bacterial transcription factor Rex to an engineered promoter. The system enabled noninvasive measurements, revealed substantial redox changes in respiratory-chain mutants, and supported enrichment of rare high-NADH cells in pooled screens.